5th Circ. Hands Win To Novartis In Bone Drug Action
The Fifth Circuit on Tuesday affirmed the dismissal of a product liability lawsuit brought against Novartis Pharmaceutical Corp. for allegedly failing to notify doctors of certain side effects of bone drugs...To view the full article, register now.
Already a subscriber? Click here to view full article